Pseudomonas aeruginosa—an environmental bacteria ... People with conditions such as COPD (smoking-related lung damage), cystic fibrosis (CF), and non-CF bronchiectasis are particularly susceptible.

today announced that the Cystic Fibrosis Foundation has made an up to USD $2.3 million equity investment (circa £1.7 million) in Owlstone to develop a breath test for Pseudomonas aeruginosa (PA ...

in this little device—really exhibit the properties of cystic fibrosis in many ways,” Ingber said. The CF airway chip is also more susceptible to bacterial infection, similar to patients. To test this ...

An international study team led by MedUni Vienna has identified two types of these so-called dysbioses in cystic fibrosis ... pathogens such as Pseudomonas aeruginosa or Staphylococcus aureus ...

Percent-predicted FEV1 measured before pregnancy did not fall 1 year after in women with highly effective cystic fibrosis ...

Purpose. The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF) lung disease is described. Dyspnea, the sensation of breathlessness or labored ...

Cystic fibrosis is a genetic disorder driven by CFTR mutations that affects the exocrine glands. Manifesting with excessively viscous mucus production, patients typically experience obstruction of ...

The company has two phase 3 development programs underway for the treatment of bronchiolitis obliterans syndrome (BOS) and non-cystic fibrosis ... Chronic Pseudomonas aeruginosa lung infection ...